Fulvestrant versus anastrazole for the treatment of advanced breast carcinoma in postmenopausal women: A prospective combined analysis of two multicenter trials

F. R. Robertson, C. K. Osborne, A. Howell, S. E. Jones, L. Mauriac, M. Ellis, U. R. Kleeberg, S. E. Come, I. Vergote, S. Gertler, A. Buzdar, A. Webster, C. Morris, Helen K Chew

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)137-138
Number of pages2
JournalWomen's Oncology Review
Volume4
Issue number2
DOIs
StatePublished - Jun 2004

ASJC Scopus subject areas

  • Oncology

Cite this

Robertson, F. R., Osborne, C. K., Howell, A., Jones, S. E., Mauriac, L., Ellis, M., Kleeberg, U. R., Come, S. E., Vergote, I., Gertler, S., Buzdar, A., Webster, A., Morris, C., & Chew, H. K. (2004). Fulvestrant versus anastrazole for the treatment of advanced breast carcinoma in postmenopausal women: A prospective combined analysis of two multicenter trials. Women's Oncology Review, 4(2), 137-138. https://doi.org/10.1080/14733400410001728474